ABDXF (Abingdon Health) Institutional Ownership: 1.52% (As of Jul. 04, 2026)


ABDXF Abingdon Health PLC ABDXF
49 GF Score
Price $0.14
GF Value $0.21
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Abingdon Health Institutional Ownership?

Abingdon Health ABDXF -1.75% 49 Institutional Ownership is 1.52% as of Jul. 04, 2026. GuruFocus rates ABDXF with a GF Score™ of 49/100 and a GF Value™ of $0.21 (Possible Value Trap). The stock has 7 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Abingdon Health's institutional ownership is 1.52%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Abingdon Health's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Abingdon Health's Float Percentage Of Total Shares Outstanding is 0.00%.

Abingdon Health Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Abingdon Health's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abingdon Health Institutional Ownership Chart

Abingdon Health Historical Data

The historical data trend for Abingdon Health can be seen below:

2025-08-31 2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31
Institutional Ownership 5.09 5.09 5.09 5.09 3.65 3.65 3.65 3.65 3.65 3.65
ABDXF
49GF Score
Abingdon Health PLC ABDXF
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abingdon Health Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 1.52% mean?
Abingdon Health (ABDXF) has a Institutional Ownership of 1.52% as of Jul. 04, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Abingdon Health and its competitors.
Is Abingdon Health's Institutional Ownership too high?
Abingdon Health's current Institutional Ownership is 1.52%. Overall, Abingdon Health has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Abingdon Health's Institutional Ownership compare to TMO and DHR?
Abingdon Health's Institutional Ownership of 1.52% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Diagnostics & Research company?
A good Institutional Ownership depends on the Medical Diagnostics & Research industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Abingdon Health and its competitors. Abingdon Health's current Institutional Ownership is 1.52%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abingdon Health stock overvalued right now?
Based on GuruFocus' analysis, Abingdon Health (ABDXF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.21, compared to a current price of $0.14 — trading 35.7% below its estimated fair value. The current Institutional Ownership is 1.52%. Abingdon Health's overall GF Score™ is 49/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Abingdon Health (ABDXF), the current Institutional Ownership is 1.52% as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abingdon Health (ABDXF) Overvalued in 2026?

Based on GuruFocus' analysis, Abingdon Health stock appears to be undervalued. The current stock price of $0.14 is trading 35.7% below its estimated GF Value™ of $0.21. GuruFocus considers Abingdon Health to be Possible Value Trap.

Key valuation signals for ABDXF:

  • Institutional Ownership: 1.52%
  • GF Value™: $0.21 vs. price of $0.14 (35.7% below fair value)
  • GF Score™: 49/100 with 7 warning signs

No single metric tells the full story. See the ABDXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abingdon Health Business Description

Other Exchanges ABDX:UK
Address York Biotech Campus, Sand Hutton, York, GBR, YO41 1LZ
Abingdon Health PLC develops, manufactures, and distributes diagnostic devices and provides regulatory consultancy to diagnostics businesses. It offers integrated lateral flow CRO/CDMO services covering feasibility, manufacturing, packaging, kitting, documentation, and commercial support. Segments include Contract Development (milestone-based third-party work, revenue over time by completion), Contract Manufacturing (development/manufacturing via daily consultancy, revenue at customer control point), Product Sales (AbC-19TM, Pocket Diagnostic, PCRD tests, research antibodies, carriage; point in time), and Regulatory Services (IVD/medical device compliance, revenue over time), with key revenue from Regulatory Services. It operates in the UK, USA/Canada, Europe, and rest of world.
49GF Score

Get the complete analysis for ABDXF

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.14
Price
$0.21
GF Value